204 related articles for article (PubMed ID: 11336466)
21. Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trial.
Courneya KS; McKenzie DC; Mackey JR; Gelmon K; Reid RD; Friedenreich CM; Ladha AB; Proulx C; Vallance JK; Lane K; Yasui Y; Segal RJ
Cancer; 2008 Apr; 112(8):1845-53. PubMed ID: 18306372
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
23. Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinoma.
Oh WK; Tully P; Kantoff PW; Regan MM
Cancer; 2003 May; 97(9):2171-9. PubMed ID: 12712468
[TBL] [Abstract][Full Text] [Related]
24. Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER-2+ breast cancer: a survey of oncologists.
Hurria A; Wong FL; Pal S; Chung CT; Bhatia S; Mortimer J; Somlo G; Hurvitz S; Villaluna D; Naeim A
Oncologist; 2009 Sep; 14(9):883-90. PubMed ID: 19726455
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
[TBL] [Abstract][Full Text] [Related]
26. Lung cancer treatment in New Zealand: physician's attitudes.
Christmas T; Findlay M
N Z Med J; 2004 Jun; 117(1196):U931. PubMed ID: 15280935
[TBL] [Abstract][Full Text] [Related]
27. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
28. [Effective treatment strategy in elderly breast cancer patients].
Boér K
Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
[TBL] [Abstract][Full Text] [Related]
29. Is adjuvant therapy for older patients with node (+) early breast cancer cost-effective?
Naeim A; Keeler EB
Breast Cancer Res Treat; 2005 Nov; 94(2):95-103. PubMed ID: 16261407
[TBL] [Abstract][Full Text] [Related]
30. Oncologists' attitudes to treatment of cancer patients.
Gilbar O; Cohen BZ
Death Stud; 1995; 19(4):303-13. PubMed ID: 10160548
[TBL] [Abstract][Full Text] [Related]
31. Palliative chemotherapy preferences and factors that influence patient choice in incurable advanced cancer.
Kim MK; Lee JL; Hyun MS; Do YR; Song HS; Kim JG; Bae SH; Ryoo HM; Park KU; Lee KH
Jpn J Clin Oncol; 2008 Jan; 38(1):64-70. PubMed ID: 18238880
[TBL] [Abstract][Full Text] [Related]
32. Personalized medical treatment strategies for patients with chronic myeloid leukemia.
Burton C; Marin D; Apperley J
Expert Rev Anticancer Ther; 2005 Apr; 5(2):343-53. PubMed ID: 15877530
[TBL] [Abstract][Full Text] [Related]
33. Factors affecting patients' perceptions of choice regarding adjuvant chemotherapy for breast cancer.
Jansen SJ; Otten W; Stiggelbout AM
Breast Cancer Res Treat; 2006 Sep; 99(1):35-45. PubMed ID: 16541318
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant chemotherapy for breast cancer: how presentation of recurrence risk influences decision-making.
Chao C; Studts JL; Abell T; Hadley T; Roetzer L; Dineen S; Lorenz D; YoussefAgha A; McMasters KM
J Clin Oncol; 2003 Dec; 21(23):4299-305. PubMed ID: 14581440
[TBL] [Abstract][Full Text] [Related]
35. Are older cancer patients being referred to oncologists? A mail questionnaire of Ontario primary care practitioners to evaluate their referral patterns.
Townsley CA; Naidoo K; Pond GR; Melnick W; Straus SE; Siu LL
J Clin Oncol; 2003 Dec; 21(24):4627-35. PubMed ID: 14673052
[TBL] [Abstract][Full Text] [Related]
36. Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center.
Fadul N; Elsayem A; Palmer JL; Del Fabbro E; Swint K; Li Z; Poulter V; Bruera E
Cancer; 2009 May; 115(9):2013-21. PubMed ID: 19235253
[TBL] [Abstract][Full Text] [Related]
37. Activity and tolerability of a combined palliative chemotherapy with mitomycin C, folinate, and 5-Fluorouracil in patients with advanced breast cancer after intensive pretreatment: a retrospective analysis.
Eichbaum MH; Gast AS; Schneeweiss A; Bruckner T; Sohn C
Am J Clin Oncol; 2007 Apr; 30(2):139-45. PubMed ID: 17414462
[TBL] [Abstract][Full Text] [Related]
38. Oncologist preferences for health states associated with the treatment of advanced ovarian cancer.
Hess LM; Malone DC; Skrepnek GH; Reed PG; Armstrong E; Coons SJ
Appl Health Econ Health Policy; 2010; 8(4):217-23. PubMed ID: 20578777
[TBL] [Abstract][Full Text] [Related]
39. The use of palliative chemotherapy in pediatric oncology patients: a national survey of pediatric oncologists.
Kang TI; Hexem K; Localio R; Aplenc R; Feudtner C
Pediatr Blood Cancer; 2013 Jan; 60(1):88-94. PubMed ID: 23024072
[TBL] [Abstract][Full Text] [Related]
40. Prescribers' attitudes toward elderly breast cancer patients. Discrimination or empathy?
Protière C; Viens P; Rousseau F; Moatti JP
Crit Rev Oncol Hematol; 2010 Aug; 75(2):138-50. PubMed ID: 19854059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
